Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ismaela Anna Vascotto
Observed names:
I.A. VASCOTTO,
I.A. Vascotto,
I.S. Vascotto,
ISMAELA ANNA VASCOTTO,
Ismaela Vascotto
Institutions:
University of Salento,
Azienda Ospedaliero-Universitaria Careggi,
Ospedale Vito Fazzi,
University of Florence
Observed institutions:
University of Salento,
Azienda Ospedaliero-Universitaria Careggi,
Ospedale Vito Fazzi,
University of Florence
ORCID:
0009-0003-9594-1451
Observed ORCID:
0009-0003-9594-1451
OpenAlex ID:
A5092083647
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies
2024
·
Giandomenico Roviello
, Irene De Gennaro
, et al.
·
Genes
·
30
PDF
Platinum-based chemotherapy in metastatic prostate cancer: what possibilities?
2023
·
Martina Catalano
, Andrea Lapucci
, et al.
·
Cancer Chemotherapy and Pharmacology
·
18
PDF
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
2024
·
Elisabetta Gambale
, Marco Maruzzo
, et al.
·
Clinical Genitourinary Cancer
·
12
PDF
Real-world effectiveness of Avelumab maintenance in advanced urothelial carcinoma: results from the Italian multicenter MALVA study (Meet-URO 25)
2025
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
The Oncologist
·
5
PDF
Ulcerative colitis and colorectal cancer: Pathogenic insights and precision strategies for prevention and treatment
2025
·
Martina Catalano
, Enrico Mini
, et al.
·
World Journal of Gastrointestinal Oncology
·
5
Evaluating perineural invasion severity in head and neck cutaneous squamous cell carcinomas to refine prognostic accuracy: A retrospective case-control study
2025
·
Filippo Nozzoli
, Silvia Mancini
, et al.
·
EJC Skin Cancer
·
4
PDF
Immune Checkpoint Inhibitor-Related Pneumonitis in Renal Cell Carcinoma: Clinical Features, Mechanisms, and Lessons from Lung Cancer
2026
·
Kristian Shtembari
, Martina Catalano
, et al.
·
Biomolecules
·
2
PDF
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
2026
·
Ismaela Anna Vascotto
, Filippo Antonica
, et al.
·
Journal of Clinical Oncology
·
2
A Snapshot from the Italian Clinical Practice Regarding Efficacy and Utility Rate of Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: The RealBLADDER Study
2025
·
ELISABETTA GAMBALE
, ROBERTA GIORGIONE
, et al.
·
In Vivo
·
2
PDF
Successful Use of Cemiplimab in a Very Elderly Patient With Cutaneous Squamous Cell Carcinoma
2024
·
ELISABETTA GAMBALE
, GIULIA VENTURI
, et al.
·
Cancer Diagnosis & Prognosis
·
2
PDF
13P First-line CEMiplimab in metastatic PENile squamous cell carcinoma: The CemPen study
2024
·
E. Gambale
, I.A. Vascotto
, et al.
·
ESMO Open
·
2
Clinical and pathological predictors of early recurrence after neoadjuvant cisplatin gemcitabine in muscle invasive bladder cancer in the RealBLADDER study
2026
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
Scientific Reports
·
1
PDF
2658eP Prognostic validation of the meet-URO score compared with the IMDC score in metastatic renal cell carcinoma (mRCC) patients receiving first-line systemic treatment (Meet-URO 33 study)
2025
·
S.E. Rebuzzi
, S. Buti
, et al.
·
Annals of Oncology
·
1
Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer
2024
·
Giandomenico Roviello
, Ismaela Anna Vascotto
, et al.
·
Frontiers in Immunology
·
1
PDF
Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies
2026
·
Giandomenico Roviello
, Kristian Shtembari
, et al.
·
Expert Review of Anticancer Therapy
Oligoprogressive Prostate Cancer: Can Metastasis-Directed Therapy Prolong the Benefit of Systemic Treatment?
2026
·
Giandomenico Roviello
, Kristian Shtembari
, et al.
·
Clinical Genitourinary Cancer
PDF
Rescue Plerixafor-based Mobilization and Outcomes of Salvage High-dose Chemotherapy in Relapsed/Refractory Germ Cell Tumors: A Large Single-center Experience
2026
·
Sara Bleve
, Maria Concetta Cursano
, et al.
·
Clinical Genitourinary Cancer
Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention
2026
·
Martina Izzi
, Andrea Lapucci
, et al.
·
Pharmacology & Therapeutics
PDF
Effectiveness and safety of avelumab maintenance in patients aged ≥75 years with advanced urothelial cancer: a sub-analysis of the meet-URO 25 (MALVA) study
2026
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
Frontiers in Immunology
PDF
Case Report: Niraparib–abiraterone in HRR-mutated metastatic castration-resistant prostate cancer: clinical insights from five cases
2026
·
Ismaela Anna Vascotto
, Martina Catalano
, et al.
·
Frontiers in Oncology
PDF
Therapeutic sequencing and role of cabozantinib after immunotherapy in metastatic renal cell carcinoma
2026
·
Martina Catalano
, Jacopo Venturini
, et al.
·
Critical Reviews in Oncology/Hematology
Concomitant medications and survival outcomes in patients receiving avelumab maintenance for advanced urothelial carcinoma: sub analysis of Meet-URO 25 study
2026
·
Giandomenico Roviello
, Martina Catalano
, et al.
·
Clinical Genitourinary Cancer
PDF
Site and number of metastases predict outcomes in avelumab maintenance for advanced UC: results from meet-URO 25
2026
·
Giandomenico Roviello
, Elisabetta Gambale
, et al.
·
Cancer Immunology Immunotherapy
PDF
Re: ctDNA-guided Adjuvant Atezolizumab in Muscle-invasive Bladder Cancer
2026
·
Giandomenico Roviello
, Ismaela Anna Vascotto
, et al.
·
European Urology
PDF
Second-line therapies of Metastatic Renal Cell Carcinoma (mRCC) after 1st line immune-combinations (ICI-combos) (Meet-URO 33 study)
2025
·
D. Bimbatti
, A. Acunzo
, et al.
·
European Urology Open Science
Show more works
View as search
Works count:
31
Citation count:
87
H-index:
5
I10-index:
3
Year
Topic
Type